Display options
Cite
Zazo Seco C, Castells-Nobau A, Joo SH, et al. A homozygous FITM2 mutation causes a deafness-dystonia syndrome with motor regression and signs of ichthyosis and sensory neuropathy. Dis Model Mech. 2016;10(2):105-118doi: 10.1242/dmm.026476.
Zazo Seco, C., Castells-Nobau, A., Joo, S. H., Schraders, M., Foo, J. N., van der Voet, M., Velan, S. S., Nijhof, B., Oostrik, J., de Vrieze, E., Katana, R., Mansoor, A., Huynen, M., Szklarczyk, R., Oti, M., Tranebjærg, L., van Wijk, E., Scheffer-de Gooyert, J. M., Siddique, S., Baets, J., de Jonghe, P., Kazmi, S. A., Sadananthan, S. A., van de Warrenburg, B. P., Khor, C. C., Göpfert, M. C., Qamar, R., Schenck, A., Kremer, H., & Siddiqi, S. (2017). A homozygous FITM2 mutation causes a deafness-dystonia syndrome with motor regression and signs of ichthyosis and sensory neuropathy. Disease models & mechanisms, 10(2), 105-118. https://doi.org/10.1242/dmm.026476
Zazo Seco, Celia, et al. "A homozygous FITM2 mutation causes a deafness-dystonia syndrome with motor regression and signs of ichthyosis and sensory neuropathy." Disease models & mechanisms vol. 10,2 (2017): 105-118. doi: https://doi.org/10.1242/dmm.026476
Zazo Seco C, Castells-Nobau A, Joo SH, Schraders M, Foo JN, van der Voet M, Velan SS, Nijhof B, Oostrik J, de Vrieze E, Katana R, Mansoor A, Huynen M, Szklarczyk R, Oti M, Tranebjærg L, van Wijk E, Scheffer-de Gooyert JM, Siddique S, Baets J, de Jonghe P, Kazmi SA, Sadananthan SA, van de Warrenburg BP, Khor CC, Göpfert MC, Qamar R, Schenck A, Kremer H, Siddiqi S. A homozygous FITM2 mutation causes a deafness-dystonia syndrome with motor regression and signs of ichthyosis and sensory neuropathy. Dis Model Mech. 2017 Feb 01;10(2):105-118. doi: 10.1242/dmm.026476. Epub 2016 Dec 15. PMID: 28067622; PMCID: PMC5312003.
Copy Download .nbib Format: NLM
Share it on

Dis Model Mech. 2017 Feb 01;10(2):105-118. doi: 10.1242/dmm.026476. Epub 2016 Dec 15.

A homozygous FITM2 mutation causes a deafness-dystonia syndrome with motor regression and signs of ichthyosis and sensory neuropathy.

Disease models & mechanisms

Celia Zazo Seco, Anna Castells-Nobau, Seol-Hee Joo, Margit Schraders, Jia Nee Foo, Monique van der Voet, S Sendhil Velan, Bonnie Nijhof, Jaap Oostrik, Erik de Vrieze, Radoslaw Katana, Atika Mansoor, Martijn Huynen, Radek Szklarczyk, Martin Oti, Lisbeth Tranebjærg, Erwin van Wijk, Jolanda M Scheffer-de Gooyert, Saadat Siddique, Jonathan Baets, Peter de Jonghe, Syed Ali Raza Kazmi, Suresh Anand Sadananthan, Bart P van de Warrenburg, Chiea Chuen Khor, Martin C Göpfert, Raheel Qamar, Annette Schenck, Hannie Kremer, Saima Siddiqi

Affiliations

  1. Department of Otorhinolaryngology, Hearing and Genes, Radboud University Medical Center, Nijmegen 6525GA, The Netherlands.
  2. The Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen 6525GA, The Netherlands.
  3. Department of Human Genetics, Radboud University Medical Center, Nijmegen 6525GA, The Netherlands.
  4. Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen 6525GA, The Netherlands.
  5. Department of Cellular Neurobiology, University of Göttingen, Göttingen 37077, Germany.
  6. Human Genetics, Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore 138672, Singapore.
  7. Laboratory of Molecular Imaging, Singapore Bioimaging Consortium, A*STAR, Clinical Imaging Research Centre, NUS-A*STAR, Singapore 138667, Singapore.
  8. Singapore Institute for Clinical Sciences, A*STAR, Clinical Imaging Research Centre, NUS-A*STAR, Singapore 117609, Singapore.
  9. Institute of Biomedical and Genetic Engineering (IBGE), Islamabad 44000, Pakistan.
  10. Center for Molecular and Biomolecular Informatics, Radboud University Medical Center, Nijmegen 6525GA, The Netherlands.
  11. Department of Molecular Developmental Biology, Radboud University, Nijmegen 6525GA, The Netherlands.
  12. Wilhelm Johannsen Centre for Functional Genome Research, Department of Cellular and Molecular Medicine (ICMM), The Panum Institute, University of Copenhagen, Copenhagen 2200, Denmark.
  13. Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Bispebjerg Hospital/Rigshospitalet, Copenhagen 2400, Denmark.
  14. Clinical Genetic Clinic, Kennedy Center, Copenhagen University Hospital, Rigshospitalet, Glostrup 2600, Denmark.
  15. National Institute of Rehabilitation Medicine (NIRM), Islamabad 44000, Pakistan.
  16. Neurogenetics Group, VIB-Department of Molecular Genetics, University of Antwerp, Antwerp 2610, Belgium.
  17. Department of Neurology, Antwerp University Hospital, Antwerp 2000, Belgium.
  18. Laboratories of Neurogenetics and Neuropathology, Institute Born-Bunge, University of Antwerp, Antwerp 2000, Belgium.
  19. Department of Neurology, Radboud University Medical Center, Nijmegen 6525GA, The Netherlands.
  20. Singapore Eye Research Institute, Singapore 168751, Singapore.
  21. Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 168751, Singapore.
  22. COMSATS Institute of Information Technology, Islamabad 45550, Pakistan.
  23. Al-Nafees Medical College & Hospital, Isra University, Islamabad 45600, Pakistan.

PMID: 28067622 PMCID: PMC5312003 DOI: 10.1242/dmm.026476

Abstract

A consanguineous family from Pakistan was ascertained to have a novel deafness-dystonia syndrome with motor regression, ichthyosis-like features and signs of sensory neuropathy. By applying a combined strategy of linkage analysis and whole-exome sequencing in the presented family, a homozygous nonsense mutation, c.4G>T (p.Glu2*), in FITM2 was identified. FITM2 and its paralog FITM1 constitute an evolutionary conserved protein family involved in partitioning of triglycerides into cellular lipid droplets. Despite the role of FITM2 in neutral lipid storage and metabolism, no indications for lipodystrophy were observed in the affected individuals. In order to obtain independent evidence for the involvement of FITM2 in the human pathology, downregulation of the single Fitm ortholog, CG10671, in Drosophila melanogaster was pursued using RNA interference. Characteristics of the syndrome, including progressive locomotor impairment, hearing loss and disturbed sensory functions, were recapitulated in Drosophila, which supports the causative nature of the FITM2 mutation. Mutation-based genetic counseling can now be provided to the family and insight is obtained into the potential impact of genetic variation in FITM2.

© 2017. Published by The Company of Biologists Ltd.

Keywords: Drosophila; Dystonia; FITM2; Hearing impairment; Lipid droplets; Motor development

References

  1. J Exp Biol. 2008 Feb;211(Pt 3):341-53 - PubMed
  2. Curr Opin Cell Biol. 2015 Aug;35:91-7 - PubMed
  3. Development. 1993 Jun;118(2):401-15 - PubMed
  4. Nature. 2011 Mar 24;471(7339):473-9 - PubMed
  5. Nat Neurosci. 2006 Aug;9(8):999-1000 - PubMed
  6. Neuroscience. 2005;136(3):661-80 - PubMed
  7. PLoS One. 2010 May 24;5(5):e10796 - PubMed
  8. J Vis Exp. 2011 Mar 11;(49):null - PubMed
  9. Am J Hum Genet. 2005 Jun;76(6):1081-6 - PubMed
  10. Methods. 2001 Dec;25(4):402-8 - PubMed
  11. PLoS Biol. 2009 Sep;7(9):e1000200 - PubMed
  12. Mov Disord. 2013 Jun;28(6):795-803 - PubMed
  13. Curr Biol. 2011 Apr 12;21(7):592-7 - PubMed
  14. Nat Genet. 2001 Aug;28(4):365-70 - PubMed
  15. Nat Genet. 2007 Jun;39(6):715-20 - PubMed
  16. Brain. 2009 Jan;132(Pt 1):8-15 - PubMed
  17. Nature. 2010 Feb 18;463(7283):913-8 - PubMed
  18. Brain. 2007 Mar;130(Pt 3):862-74 - PubMed
  19. J Magn Reson Imaging. 2008 Oct;28(4):937-45 - PubMed
  20. Proteomics. 2007 Dec;7(23 ):4228-34 - PubMed
  21. J Cell Biol. 2015 Oct 26;211(2):261-71 - PubMed
  22. Hum Mol Genet. 2011 Oct 1;20(19):3831-40 - PubMed
  23. Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):94-9 - PubMed
  24. Cold Spring Harb Perspect Biol. 2011 Mar 01;3(3):null - PubMed
  25. J Cell Biol. 2014 Mar 3;204(5):635-46 - PubMed
  26. Br J Pharmacol. 2009 Dec;158(7):1820-34 - PubMed
  27. Curr Biol. 2006 Jan 10;16(1):12-23 - PubMed
  28. Am J Hum Genet. 2014 Aug 7;95(2):131-42 - PubMed
  29. Hum Mol Genet. 2011 Aug 1;20(15):3022-30 - PubMed
  30. Nat Genet. 2011 Dec 11;44(1):67-72 - PubMed
  31. Mol Cell Biol. 2012 Oct;32(19):3949-62 - PubMed
  32. Nat Genet. 1996 Oct;14(2):177-80 - PubMed
  33. Cell Metab. 2007 Oct;6(4):257-66 - PubMed
  34. PLoS Biol. 2011 Jan 04;9(1):e1000569 - PubMed
  35. Brain. 2013 Jul;136(Pt 7):2038-49 - PubMed
  36. PLoS Genet. 2011 Apr;7(4):e1001364 - PubMed
  37. J Biol Chem. 2011 Dec 9;286(49):42188-99 - PubMed
  38. Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19581-6 - PubMed
  39. Am J Med Genet B Neuropsychiatr Genet. 2015 Jun 10;:null - PubMed
  40. Cell. 2012 Aug 31;150(5):1042-54 - PubMed
  41. Nat Genet. 2002 Jan;30(1):97-101 - PubMed
  42. J Biol Chem. 2014 Apr 4;289(14):9560-72 - PubMed
  43. Am J Hum Genet. 2007 Sep;81(3):559-75 - PubMed
  44. Nat Protoc. 2008;3(5):866-76 - PubMed
  45. Hum Mol Genet. 2012 Jan 15;21(2):287-99 - PubMed
  46. J Biol Chem. 2015 Oct 16;290(42):25686-99 - PubMed
  47. Proc Natl Acad Sci U S A. 1967 Sep;58(3):1112-9 - PubMed
  48. Magn Reson Med. 1993 Dec;30(6):672-9 - PubMed
  49. J Anat. 1980 Oct;131(Pt 3):519-23 - PubMed
  50. Nature. 2007 Jul 12;448(7150):151-6 - PubMed
  51. Hum Genet. 2013 Oct;132(10):1077-130 - PubMed
  52. Mol Cells. 2009 Jan 31;27(1):89-97 - PubMed
  53. Curr Biol. 2015 Jun 1;25(11):R470-81 - PubMed
  54. J Neurosci. 2012 May 30;32(22):7466-76 - PubMed
  55. J Magn Reson Imaging. 2015 Apr;41(4):924-34 - PubMed
  56. Protein Eng Des Sel. 2004 Jan;17 (1):107-12 - PubMed
  57. Mol Gen Genet. 1997 Aug;255(6):561-9 - PubMed
  58. Mol Biol Cell. 2015 Feb 15;26(4):726-39 - PubMed
  59. Trends Genet. 2012 May;28(5):221-32 - PubMed
  60. Hear Res. 2015 Dec;330(Pt A):26-38 - PubMed
  61. Annu Rev Biochem. 2012;81:687-714 - PubMed
  62. J Acoust Soc Am. 2004 Aug;116(2):1016-24 - PubMed
  63. Hum Genet. 2010 Sep;128(3):281-91 - PubMed

Substances

MeSH terms

Publication Types

Grant support